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Available online 11 July 2005892Recently, using HIV-1-derived lentivectors, we obtained efficient transduction of primary human B
lymphocytes cocultured with murine EL-4 B5 thymoma cells, but not of isolated B cells activated by
CD40 ligation. Coculture with a cell line is problematic for gene therapy applications or study of
gene functions. We have now found that transduction of B cells in a system using CpG DNA was
comparable to that in the EL-4 B5 system. A monocistronic vector with a CMV promoter gave 32 F
4.7% green fluorescent protein (GFP)+ cells. A bicistronic vector, encoding IL-4 and GFP in the first
and second cistrons, respectively, gave 14.2 F 2.1% GFP+ cells and IL-4 secretion of 1.3 F 0.2 ng/105
B cells/24 h. This was similar to results obtained in CD34+ cells using the elongation factor-1A
promoter. Activated memory and naive B cells were transducible. After transduction with a
bicistronic vector encoding a viral FLIP molecule, vFLIP was detectable by FACS or Western blot in
GFP+, but not in GFP, B cells, and 57% of sorted GFP+ B cells were protected against Fas ligand-
induced cell death. This system should be useful for gene function research in primary B cells and
development of gene therapies.Key Words: HIV-1-derived lentivectors, bicistronic vectors, human primary B lymphocytes,
CpG DNA, viral FLIPINTRODUCTION
Optimization of methods for gene delivery into primary
human cells is important for research on gene functions
and development of gene therapies [1]. Gene transfer into
primary human B lymphocytes has been notoriously
difficult. Successful applications of nonviral methods to
functional assays of transgenes have not been reported
for these cells. Epstein–Barr virus vectors so far have been
tested only in B cell lines [2]. Murine oncoretroviral
vectors gave low transduction efficiency (of up to about
4%) in primary human B cells; they could be utilized to
study effects detectable by very sensitive methods, such
as immunoglobulin (Ig) class-switch recombination
detectable by PCR [3]. HIV-1-derived lentivectors gave
efficient transduction of various immature and mature
human hematopoietic cells [4–6]. Transgene expression
restricted to B lymphocytes was obtained by grafting
lentivector-transduced CD34+ progenitors into NOD/
SCID mice [7]. T lymphocytes could be transduced after
activation, at least from the G0 to the G1 stage of the cell
cycle [5,6]. But primary human B cells activated intoproliferation by crosslinking of CD40 in the presence of
various cytokines were very poorly transducible [8,9].
Recently with such vectors we obtained efficient trans-
duction of primary B cells cocultured with irradiated
murine EL-4 B5 thymoma cells; monocistronic vectors
with the human cytomegalovirus (CMV) or elongation
factor-1a (EF-1a) internal promoter gave 27 F 12% green
fluorescent protein (GFP)+ cells [9].
For gene therapy applications, however, a cell line
potentially adds risks, such as generation of recombinant
viruses. For studies of gene functions a handicap is that
the functions of the thymoma cells have not yet been
molecularly characterized. The first aim of this study was
to find a culture system for transduction with HIV vectors
of isolated B cells activated by defined stimuli. The LPS
receptor, Toll-like receptor-4 (TLR4), is lacking in human
B cells. But TLR9, the endosomal receptor for bacterial
DNA (short single-stranded DNA containing nonmethy-
lated CpG motifs; CpG DNA), is constitutively expressed
in memory human B cells and rapidly upregulated by
anti-Ig antibody—which mimics an antigen signal—inMOLECULAR THERAPY Vol. 12, No. 5, November 2005
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transduction of B cells cultured with CpG DNA, anti-Ig,
IL-2, and IL-10.
The second aim was to test bicistronic HIV vectors
encoding the transgene in the first cistron and GFP in the
second cistron, downstream of the internal ribosomal
entry site (IRES). The vectors contained the woodchuck
hepatitis virus posttranscriptional regulatory element
(WPRE) [12]. First, we tested a cytokine gene; this allows
quantitation of secreted protein. IL-4 was chosen because
it was produced neither by B cells nor in our CD34+ cell-
derived cultures. CD34+ hematopoietic cells were utilized
as a primary cell control known to be transducible with
various HIV vector constructs [13,14]. As shown below,
with the IL-4 vector using the CMV promoter the
cytokine secretion rate of B cells was comparable to that
of CD34+-derived cells transduced by this vector with the
EF-1a promoter. Second, we tested a viral FLIP gene. Viral
FLIP proteins, like the short isoform of cellular FLIP,
competitively replace the caspase in the proximal signal-
ing complex that forms after the ligation of death
receptors, such as Fas [15]. Thus, transduction should
produce a positive (survival enhancing) effect rather than
a loss of function readout only. Such an effect was
obtained in Fas ligand (FasL)-exposed B cells.
RESULTS AND DISCUSSION
B Cell Transduction in a Culture System Using CpG
DNA
We found that peripheral blood B cells stimulated by
CpG DNA, anti-Ig antibody, and the cytokines IL-2 andFIG. 1. GFP MFI in B cells transduced with monocistronic or bicistronic HIV vector
cultured in the CpG DNA system. Virus particles for the indicated vectors were ad
viable cells on day 6. 2-D plots show staining with PE-anti-CD19 mAb on the y axi
of these cells are indicated by upper and lower numbers, respectively, in the his
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transduced by HIV vectors. For monocistronic (GFP) and
bicistronic (IL-4–IRES–GFP) vectors, the mean fluores-
cence intensity (MFI) of GFP+ B cells was always higher
(2.5-fold or more) with the CMV than with the EF-1a
internal promoter (Fig. 1), confirming our previous
findings with monocistronic vectors [9]. As expected,
the percentages of GFP+ cells were lower with the
bicistronic compared to the monocistronic vectors (3-
or 2.3-fold by the mean, respectively, for the EF-1a or
CMV promoter; for the CMV promoter, mean data are
shown in Fig. 2, CpG).
The CG-rich oligonucleotides C274 (21 bases) and
2006 (24 bases), which caused optimal B cell proliferation
in the study by Marshall et al. [16], both allowed for
efficient transduction, whereas oligonucleotide C661,
with all CG inverted to GC, gave 20-fold lower prolifer-
ation and transduction. Vectors had to be added to the B
cell cultures on day 2 or later. At a multiplicity of
infection of 20 HeLa cell-transducing units per B cell
(m.o.i. of 20) the numbers of GFP+ cells were 1.2-fold
higher by the mean than at an m.o.i. of 10, but at an
m.o.i. of 30 or higher the numbers progressively
decreased. We also found this both with vector particles
added to culture plates by low-speed centrifugation at
1000g and with the particles left in the supernatant,
whereas virus-free supernatant of the virus-producer cells
showed no toxicity. In B cells, exposure to vector caused
increase in annexin V+ cells (on day 4, from 13% in
control culture to 28% in culture with virus added on day
3 at an m.o.i. of 80), indicating that apoptosis was
involved. Our vectors were not toxic for T cells ands was higher with the CMV than with the EF-1a internal promoter. B cells were
ded to parallel cultures on day 3 at an m.o.i. of 10. FACS analysis was done in
s (isotype controls gave b0.5% background). Percentages of GFP+ cells and MFI
tograms.
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FIG. 2. Differences in B cell transducibility by HIV vectors under various culture
conditions. Vectors CMV:GFP or CMV:IL4-GFP were added on day 3 (m.o.i. o
10) to the CD40L system (CD40L), CpG DNA system (CpG), CpG DNA system
in the presence of CD40L (CpG + CD40L), EL-4 B5 system (EL-4 B5), or EL-4
B5 system in the presence of CD40L (EL-4 B5 + CD40L). FACS analysis wa
done in viable cells on day 6 or 7. Shown are means F 1 SEM for percentage
of GFP+ B cells from nine independent experiments for each culture condition
Transduction in CpG versus CpG + CD40L, and in EL-4 B5 versus EL-4 B5 +
CD40L, was compared in parallel experiments. Significant, opposite effects o
CD40L on transducibility were found with both vectors (**P b 0.001; *P b
0.05; by two-sided t test).
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fCD34+ cells. This may reflect the fact that, in general, B
cells are more prone to apoptosis in culture than many
other cells.
Comparison of Different B Cell Culture Systems
Viable cell expansion in the CpG DNA system set up
with total peripheral blood B cells was fivefold by the
mean in 10 days. Individual B cells proliferate very
heterogeneously in this system [10]. At least fivefold
higher B cell expansion was obtained in the system using
EL-4 B5 murine thymoma cells as helper T cells [9,17].
But the percentages of transduced B cells among the
viable cells analyzed on day 6 or 7 were very similar in
both systems (Fig. 2, CpG and EL-4 B5; there were about
30 and 14% GFP+ cells, respectively, for vectors
CMV:GFP and CMV:IL4-GFP). Since activated B cells
proliferated and outnumbered nonproliferating cells,
this means that proliferating B cells were similarly
transduced in both systems. Various cell types, e.g., T
cells [5,6], after some activation become transducible
with lentivectors even if they do not divide. So far this
could not be studied with B cells, because—unlike T
cells—B cell populations could not be maintained in an
activated, nondividing state.
In agreement with our previous data [9], however,
transducibility was very low in B cells proliferating in
response to soluble CD40 ligand, IL-2, and IL-10 (CD40L,
Fig. 2). Moreover, when we added CD40L to the CpG
DNA system (CpG + CD40L), thymidine incorporation
was enhanced 2-fold compared to the standard CpG DNA
system, but the transducibility became 3.2-fold lower by
the mean ( P b 0.001 by two-sided t test; nine independ-ent, paired experiments). By contrast, adding CD40L to
the EL-5 B5 system (EL-4 B5 + CD40L) gave not only
slightly increased thymidine incorporation compared to
the standard EL-4 B5 system, but also 1.3-fold higher B
cell transducibility ( P b 0.05; also nine independent,
paired experiments). In those experiments in which the B
response in the EL-4 B5 system was relatively weak,
addition of CD40L could double the percentage of GFP+ B
cells. In addition we found that CD40L enhanced B
transduction in total peripheral blood lymphocytes
stimulated with pokeweed mitogen. Anti-Ig did not
enhance transducibility in the CD40L system, but B cells
stimulated with CpG DNA only were transducible (about
15% GFP+ cells with monocistronic vector).
Thus, it appeared that, in particular, B cells stimulated
via CD40 in the absence of other T cell signals (an
artificial condition) somehow resisted transduction by
HIV vectors. The vectors did not cause more annexin V
expression in CD40L-stimulated than in CpG DNA-
stimulated B cells. Serafini et al. [18] found that in B cells
activated via CD40 the transduction was blocked at an
early stage. It is possible that innate cellular defenses,
such as mechanisms involving TRIM5 or APOBEC3
antiretroviral factors [19,20], are involved; they might
be triggered under certain (abnormal?) cell activation
conditions in vivo.
Transduction of Naive and Memory B Cells
In accordance with published data [10,11], anti-Ig
enhanced the proliferation of naRve (CD27), but not
of memory (CD27+), B cells in the CpG DNA system
(2.9-fold by the mean; Fig. 3A). Even with anti-Ig,
proliferation was 2.1-fold lower in naive than in
memory B cultures. However, after 7 days of culture
the majority of naive B cells expressed CD27, and in
cultures with vector these cells expressed GFP very
similar to memory B cells (Fig. 3B shows data represen-
tative of two other independent experiments). CD27 is
an activation marker for naive B cells [21]. The naive B
cells that remained CD27 were not transduced. On the
other hand, cultures set up with memory B cells always
contained some CD27 cells after culture, but these cells
were transduced. Since some B cells express CD27 ligand
[21], these may have been cells with ligand-modulated
CD27. In any case, the data show that activated naive
and memory B cells were transducible in the CpG DNA
system.
IL-4 Secretion by Transduced B Cells
B cells transduced with IL-4 vectors, after cell wash,
released IL-4 during secondary culture. We studied
whether pseudotransduction (PTD) played a role, i.e.,
any viral integration-independent effects, including pas-
sive transfer of transgene proteins by the virus particles
(cells become exposed to numerous defective particles)
[9]. Therefore, we tested viruses produced using a pack-MOLECULAR THERAPY Vol. 12, No. 5, November 2005
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FIG. 3. Naive and memory B cells proliferated and were transducible in the CpG DNA system. (A) Anti-Ig antibody (aIg) enhanced thymidine incorporation by
naive (CD27, white columns), but not by memory (CD27+, black columns), B cells in the presence of CpG DNA, with or without IL-2 and IL-10 (meansF 1 SEM
of counts per minute (cpm) from three independent experiments). (B) The 2-D plots show CD27 expression and FL1 fluorescence in sorted memory and naive B
cells before (Day 0) and after culture in the CpG DNA system (Day 7), with no virus or with vector CMV:GFP added on day 3 an m.o.i. of 10. Percentages of
CD27+ cells (27+) and of GFP+ cells among the CD27+ cells (27+GF+) are indicated (experiment representative for three independent experiments). Only those
naive B cells that became CD27+ were transduced.
ARTICLEdoi:10.1016/j.ymthe.2005.05.010aging construct with a loss-of-function mutant integrase
or a vector plasmid (CMV:IL4-GFP) lacking the central
polypurine tract (cPPT) involved in nuclear translocation
[22]. We added control virus at an m.o.i. of 10 and the
others, produced in parallel, at concentrations equalized
for IL-4 concentrations in the 293T culture supernatant.
Control vector gave 13.9% GFP+ B cells (Fig. 4A) and an
IL-4 release of 1.1 ng IL-4/105 B cells/24 h (Fig. 4B). The
virus lacking integrase activity gave 0.87% GFP+ cells, but
no bright GFP+ cells, i.e., this was weak PTD that occurs
with GFP [9]. The IL-4 release was low, indicating that
about 5% of the IL-4 release obtained with the positive
control may have been due to PTD. The virus lacking the
cPPT gave 1.92% GFP+ cells, including about 1% bright
cells. The IL-4 release (6.7-fold lower than control) was
close to what one would expect for this number of bright
GFP+ cells plus PTD as estimated above. Thus, PTD played
a negligible role.
Comparison of IL-4 Secretion by B Cells and CD34+
Cells
We used CD34+ cells as a reference for work with
lentivectors. After transduction with the IL-4 vector with
the EF-1a promoter, which is optimal in these cells [13],
the GFP expression in CD34+ cell-derived cultures (Fig. 5A;
the upper histograms) was similar to that obtained in BMOLECULAR THERAPY Vol. 12, No. 5, November 2005
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intracytoplasmic IL-4 was detectable by FACS and corre-
lated with GFP expression among individual transduced
cells (lower histograms in Fig. 5A). Although B cells do
not produce IL-4 [23], a strong nonspecific staining by
the anti-IL-4 antibody in transduced and nontransduced
B cells made such detection impossible. IL-4 secretion was
also similar in B cells and CD34+-derived cells (Fig. 5B;
about 1.2 ng IL-4/105 cells/24 h). In B cells, IL-4 secretion
with the EF-1a promoter was 3.4-fold lower than with the
CMV promoter. In FACS-sorted GFP+ B cells, the IL-4
secretion increased in parallel with their enrichment (not
shown). Thus, transducibility with bicistronic vector was
similar for B and CD34+ cells. That many B cells become
secretory cells (plasma cells) was apparently not relevant
for the cytokine secretion rate. However, a considerably
lower cytokine secretion rate was reported for primary B
leukemia cells transduced with a bicistronic HIV vector
lacking the WPRE [24]. This element enhances mRNA
stability [12].
GFP expression and IL-4 secretion were stable in B cells
between days 3 and 8 after exposure to vector and in
CD34+-derived cells when followed up for 21 days. On
day 8 after exposure to vectors with the respective
optimal promoters, at an m.o.i. of 10, quantitative PCR
revealed multiple copies of GFP DNA per diploid genome895
FIG. 4. Correlation between IL-4 secretion and GFP expression in B cells exposed to different vector particles: positive control vector (CMV:IL4-GFP), vecto
plasmid deleted of the cPPT element (D cPPT), and virus made using a packaging construct with an inactive mutant integrase (No integrase). (A) GFP expression
All three types of vector particles were produced in parallel. Control vector CMV:IL4-GFP was added at an m.o.i. of 10. The other vector particles were added a
concentrations equalized for the amounts of IL-4 measured in the supernatants of the virus-producer cells. Upper and lower numbers represent percentages o
GFP+ cells and MFI, respectively. (B) IL-4 secretion rates measured in this representative experiment (means F 1 SEM of triplicate cultures).
ARTICLE doi:10.1016/j.ymthe.2005.05.010in CD34+-derived GFP+ cells (4.5 F 0.3), as expected [25],
and also in CD19+GFP+ B cells (4.8 F 0.4; meansF 1 SEM,
n = 4, i.e., two transduction experiments with mono- and
two with bicistronic vectors for each cell type and for B
cells one of each experiment in the CpG and B5 systems).FIG. 5. GFP expression and IL-4 secretion by B cells transduced with vector CMV:IL4-GFP were similar to those found in cell cultures derived from cord blood
CD34+ cells transduced with vector EF1a:IL4-GFP. (A) The upper plots show GFP expression in cell culture derived from 97% pure cord blood CD34+ cells from a
representative experiment. EF1a:IL4-GFP was added on day 1 at an m.o.i. of 20; cells were analyzed on day 5. Upper and lower numbers represent percentage
of GFP+ cells and MFI, respectively. The lower plots show a staining with PE–anti-IL-4 mAb on the y axis and GFP fluorescence on the x axis on day 5. Percentage
of cells stained by anti-IL-4 (
,,
IL
,,
),and of GFP+ cells (
,,
G
,,
) are indicated. (B) IL-4 secretion rates measured in B cells and CD34+ cell-derived cultures transduced
with the indicated vectors at an m.o.i. of 10 (means F 1 SEM from six independent experiments).
MOLECULAR THERAPY Vol. 12, No. 5, November 2005896
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t
fWe obtained overlapping results with mono- and bicis-
tronic vectors. We found at least 10-fold lower PCR
signals in GFP cells, showing low contamination by
DNA plasmids. Since vector-derived episomal DNA is
short-lived in various cells, including B cells [18], theses
sy
ARTICLEdoi:10.1016/j.ymthe.2005.05.010data indicate multiple vector integration in both cell
types.
Effects of Bicistronic Vector Expressing Viral FLIP
We then tested a bicistronic vector expressing FLAG-
tagged vFLIP of molluscum contagiosum virus [15]. We
added this vector (CMV:vFLIP-GFP) or control vector
(CMV:GFP) to B cells in the CpG DNA system on day 2
and sorted GFP+ cells on day 5 (Fig. 6A). We recultured
the cells in the presence or absence of soluble FasL. In two
experiments, transduction of vFLIP caused a 1.8- to 2.4-
fold reduction in the number of FasL-induced annexin V+
apoptotic cells after 20 h (without and with FasL,
respectively, there were 32 F 3.9 and 79 F 5.6% annexin
V+ cells for control vector versus 35F 4.4 and 57F 1.5 forFIG. 6. Detection of viral FLIP protein and of protection from FasL-induced cell d
cells transduced in the CpG DNA system with CMV:vFLIP-GFP at an m.o.i. of 10
percentages of GFP+ cells and MFI, respectively. The gating for the FACS sorting i
transduced with CMV:vFLIP-GFP, or control vector CMV:GFP, after reculture in t
counts per minute (cpm) relative to no-FasL controls (means F 1 SEM from three
(SEM in parentheses). (C) Detection of intracellular viral FLIP with anti-FLAG mAb (
in the EL-4 B5 system. Vector was added on day 3 at an m.o.i. of 10 and cells were
anti-FLAG (
,,
FL
,,
) and of GFP+ cells (
,,
G
,,
) are indicated. (D) Western blot of sorte
performed with protein equivalents of 3  105 B cells. Stainings with anti-FLAG m
kDa.
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thymidine incorporation after 48 h to detect cell survival
(Fig. 6B). Only 14 F 4% of B cells transduced with control
vector, but 63 F 12% of B cells transduced with vFLIP
vector, resisted killing by FasL. Thus, among those cells
that could be killed by FasL, 57% (range 45 to 71%) were
protected by vFLIP.
In B cells transduced in the EL-4 B5 system, intra-
cellular vFLIP was detectable with anti-FLAG mAb by
FACS and its expression correlated with GFP expression
in individual cells (Fig. 6C). Viral FLIP was also detectable
with this antibody by Western blot in sorted GFP+, but
not in GFP, B cells (Fig. 6D).
In conclusion, with an HIV-1-derived bicistronic
vector we obtained proof of principle for the testing ofeath in B cells transduced with vector CMV:vFLIP-GFP. (A) GFP expression in B
, before and after sorting of GFP+ B cells. Upper and lower numbers represent
s shown by the arrowhead. (B) Thymidine incorporation by sorted GFP+ B cells
he presence or absence of FasL. The black columns represent percentages of
independent experiments). Mean cpm in cultures with no FasL are indicated
y axis) and GFP fluorescence (x axis) in B cells transduced with CMV:vFLIP-GFP
analyzed on day 8, after 46-fold cell expansion. Percentages of cells stained by
d GFP+ and GFP B (CD19+) cells transduced as above in the EL-4 B5 system,
Ab or anti-actin antibodies are shown. Viral FLIP was detected as a band of 34
897
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culture system should be useful for such studies.
MATERIALS AND METHODS
HIV-1-Derived Vectors
A second-generation packaging system and self-inactivating HIV-1
vectors [26] with the pLoxP site in the 3VLTR [27] were utilized. The
monocistronic vector with the EF-1a internal promoter (called vector
EF1a:GFP in this study) was plasmid pWPT-GFP for which the map and
sequence are available at http://www.tronolab.unige.ch. This plasmid
carries, in the 5V to 3V direction, the cPPT element [22], the intronless
(bshortQ) EF-1a promoter, the expression cassette, and the WPRE [12].
Vector CMV:GFP was made by replacing the promoter with the human
CMV promoter [13] between the ClaI and the BamHI restriction sites. In
the bicistronic vectors, which were derived from the above vectors, the
first cistron was the transgene of interest, between the BamHI and the
SalI restriction sites, followed by the encephalomyocarditis virus IRES
[27] and GFP encoded downstream of the IRES. In the vectors EF1a:IL4-
GFP and CMV:IL4-GFP the transgene was the complete human IL-4
cDNA sequence (a kind gift from Dr. J.-F. Gauchat, formerly at the
Institut Pierre Fabre, St. Julien, France). In vector CMV:vFLIP-GFP the
transgene was the FLAG-tagged viral FLIP of human molluscum
contagiosum virus (open reading frame 159L), kindly provided by Dr.
Margot Thome of the Department of Biochemistry, University of
Lausanne [15]. In some experiments we used a vector plasmid as above,
except that it lacked the cPPT element, or a packaging construct [9]
with a loss-of-function mutant integrase (mutation D64V) [28].
Virus particles pseudotyped with vesicular stomatitis virus G glyco-
protein were produced, concentrated 100-fold by ultracentrifugation, and
titrated on HeLa cells by measurement of GFP+ cells by FACS to establish
HeLa transducing units per milliliter (usually 0.5 to 2  108), as described
[9]. Viral stocks were suspended in B cell culture medium and stored at
708C.
Cell Cultures and Transduction
Approval for research on human cells was obtained from the Ethics
Committee of the Geneva University Hospitals. Written consent was
provided for all cell samples. B cells were isolated to more than 99% purity
from buffy coats of virus-screened blood donations obtained from the
Geneva Transfusion Center using Ficoll–Hypaque centrifugation and anti-
CD19 magnetic beads (Dynal) [29]. All B cell cultures were grown in RPMI
1640 medium supplemented with 10% fetal calf serum, 2-mercaptoetha-
nol, Hepes buffer, and antibiotics as described [29].
CpG DNA system. B cells (25,000 cells/200 Al culture; flat-bottom 96-
well plates) were stimulated with CpG DNA (2.5 Ag/ml), anti-Ig
antibody (2 Ag/ml), IL-2 (50 ng/ml), and IL-10 (10 ng/ml). CpG
oligonucleotides of the published sequences C274, 2006, and C661
[16] were obtained as complete phosphorothioates synthesized to our
order by Microsynth (Balgach, Switzerland). Anti-Ig was goat F(abV)2
anti-human IgA + IgG + IgM (H+L) (Jackson ImmunoResearch). The
cytokines were from PeproTech. FACS sorting of CD27+/CD27 cells
was done as described [29].
CD40L system. B cells (50,000 cells/200 Al) were stimulated with a soluble
oligomeric CD40L (300 ng/ml), IL-2 (50 ng/ml), and IL-10 (10 ng/ml) as
described [29]. When CD40L was added to the CpG DNA system or the EL-
4 B5 system, its concentration was also 300 ng/ml.
EL-4 B5 system. B cells (3000 cells/200 Al) were stimulated with 50,000
irradiated EL-4 B5 murine thymoma cells and a mixture of human
cytokines acting on the EL-4 B5 cells (IL-1h) or the B cells (TNF-a, IL-2,
and IL-10), as described [9].
To transduce B cell cultures at different times, the big cell clusters,
which formed in all culture systems, were dispersed by gentle pipetting
(five times aspiration of the culture using 200-Al tips). Virus particles were
then added to the cultures in a volume of 2 to 4 Al, at the indicated m.o.i.
according to cell counts by microscope (B cells or B plus EL-4 B5 cells),898without further manipulations or cell wash. We found that centrifugation
of virus particles in new culture plates (spinoculation) with cell transfer
did not give better results.
CD34+ cell culture and transduction. Umbilical cord blood CD34+ cells
were isolated to N95% purity with anti-CD34 magnetic beads (Dynal),
cultured, and transduced as described [13]. Briefly, the cells (105/200 Al)
were first cultured and transduced on day 1 in the presence of
thrombopoietin (TPO). After 48 h, the cells were recultured in Iscove’s
modified Dulbecco’s medium supplemented with 10% fetal calf serum,
antibiotics, TPO, Flt3-ligand, and stem cell factor; the cells were
recultured every 6 days.
Sorting and FACS Analysis of Transduced Cells
Various GFP+ cell populations were sorted on a FACStar sorter, and
analyses of GFP+ cells were performed on a FACScan analyzer using
CellQuest software (Becton–Dickinson), at the cytofluorometry laboratory
of the Geneva Medical Center. Cells were pretreated with polyclonal
mouse Ig before staining with phycoerythrin (PE)-coupled anti-CD19 [9],
anti-CD27 [29], or anti-CD34 [13] mAb, and viable (7-amino-actino-
mycin-D low) cells were gated for analysis of GFP expression [9]. For
analysis of cytoplasmic IL-4, cells were cultured with brefeldin A (Sigma),
2.5 Ag/ml, for 3 h. For analysis of cytoplasmic IL-4 or viral FLIP, cells were
treated with Cytofix/Cytoperm and Perm/Wash solutions, followed by
AB+ serum, and then stained, respectively, with PE-coupled anti-IL-4 mAb
(Pharmingen) or anti-FLAG-M2 mAb (Sigma), which we coupled to biotin,
followed by PE-coupled streptavin (Jackson ImmunoResearch). The
isotype control was mouse IgG1. Apoptosis was assessed using the
Annexin V–PE Apoptosis Detection Kit I (Becton–Dickinson).
Other Analyses of Transduced Cells
IL-4 secretion rate. On day 2 or 3 after addition of viral particles, B cells or
CD34+ cells were harvested and washed twice in culture medium in
Eppendorf tubes, and viable, trypan blue-excluding cells were counted.
The cells were recultured as before, and after 24 h soluble IL-4 was
measured in culture supernatants by Quantikine Human IL-4 Immuno-
assay (R&D Systems).
Real-time quantitative PCR. The LightCycler system, High Pure PCR
Template Preparation Kit, and LightCycler FastStart DNA MasterPLUS SYBR
Green I kit (all from Roche) were utilized. Cells were transduced with
vectors treated with DNase I before ultracentrifugation [7]. PCR was
performed in separate assays for genomic DNA, using intron-binding
primers for h2-microglobulin (5V-GGCACTGCTGAGATACTGAT-3V,
reverse 5V-GCTAGGACAGCAGGACTTA-3V; 215-bp product) and for vector
DNA, using GFP primers (5V-GGCAAGCTGACCCTGAAGTT-3V, 5V-
GCATGGCGGACTTGAAGAAGT-3V; 149-bp product); respective plasmid
standards were utilized.
FasL assay. GFP+ cells were sorted 3 days after exposure to vector and
recultured (20,000 trypan blue-excluding cells/200 Al, triplicate cultures)
in the CpG DNA system (without anti-Ig) in the presence of soluble
oligomeric FasL (200 ng/ml) prepared as described [30]. Thymidine
incorporation was measured after 48 h including the pulsing during the
last 12 h [29] with 1 ACi (0.037 MBq) [methyl-3H]thymidine (Amersham
Pharmacia Biotech).
Western blot for viral FLIP. This was done with the ECL Western blotting
analysis system (Amersham) using 0.45-Am nitrocellulose membranes
(Bio-Rad) and Biomax chemiluminescence films (Kodak). The antibodies
were IgG1 mouse anti-FLAG-M2 mAb (Sigma) or polyclonal goat IgG anti-
actin (Santa Cruz Biotechnologies) in conjunction with horseradish
peroxidase-coupled anti-mouse or anti-goat antibodies, respectively
(Santa Cruz Biotechnologies).
ACKNOWLEDGMENTS
These studies were supported by grants from the Swiss National Science
Foundation (to D.T. and R.Z.), the European Community, and the Institut
Clayton pour la Recherche (to D.T.). K. Kvell is a member of the M.D.–Ph.D.
Program of the University of Pe´cs, Hungary.MOLECULAR THERAPY Vol. 12, No. 5, November 2005
Copyright C The American Society of Gene Therapy
ARTICLEdoi:10.1016/j.ymthe.2005.05.010RECEIVED FOR PUBLICATION JANUARY 25, 2005; REVISED APRIL 13, 2005;
ACCEPTED MAY 2, 2005.
REFERENCES
1. Somia, N., and Verma, I. M. (2000). Gene therapy: trials and tribulations. Nat. Rev.
Genet. 1: 91 – 99.
2. Basu, U., and Banerjee, S. (2004). An engineered EBV vector expressing human factor
VIII and von Willebrand factor in cultured B cells. J. Gene Med. 6: 760 – 768.
3. Ballantyne, J., et al. (1998). Efficient recombination of a switch substrate retrovector in
CD40-activated B lymphocytes: implications for the control of CH gene switch
recombination. J. Immunol. 161: 1336 – 1337.
4. Zufferey, R., et al. (1997). Multiply attenuated lentiviral vector achieves efficient gene
delivery in vivo. Nat. Biotechnol. 15: 871 – 875.
5. Unutmaz, D., et al. (1999). Cytokine signals are sufficient for HIV-1-infection of resting
human T lymphocytes. J. Exp. Med. 189: 1735 – 1746.
6. Ducrey-Rundquist, O., Guyader, M., and Trono, D. (2002). Modalities of interleukin-7-
induced human immunodeficiency virus permissiveness in quiescent T lymphocytes.
J. Virol. 76: 9103 – 9111.
7. Moreau, T., Bardin, F., Imbert, J., Chabannon, C., and Tonnelle, C. (2004). Restriction
of a transgene expression to the B-lymphoid progeny of human lentivirally transduced
CD34+ cells. Mol. Ther. 10: 45 – 56.
8. Janssens, W., et al. (2003). Efficiency of onco-retroviral and lentiviral gene transfer into
primary mouse and human B-lymphocytes is pseudotype dependent. Hum. Gene Ther.
14: 263 – 276.
9. Bovia, F., et al. (2003). Efficient transduction of primary human B lymphocytes and
nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood 101:
1727 – 1733.
10. Bernasconi, N. L., Onai, N., and Lanzavecchia, A. (2003). A role for Toll-like receptors in
acquired immunity: up-regulation of TLR9 by BCR triggering in naRve B cells and
constitutive expression in memory B cells. Blood 101: 4500 – 4504.
11. Bourke, E., et al. (2003). The toll-like receptor repertoire of human B lymphocytes:
inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.
Blood 102: 956 – 963.
12. Zufferey, R., Donello, J. E., Trono, D., and Hope, T. J. (1999). Woodchuck hepatitis virus
posttranscriptional regulatory element enhances expression of transgenes delivered by
retroviral vectors. J. Virol. 73: 2886 – 2892.
13. Salmon, P., et al. (2000). High-level transgene expression in human hematopoietic
progenitors and differentiated blood lineages after transduction with improved
lentiviral vectors. Blood 96: 3392 – 3398.
14. Schomber, T., Kalberer, C. P., Wodnar-Filipowicz, A., and Skoda, R. C. (2004). Gene
silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells. Blood 103:
4511 – 4513.MOLECULAR THERAPY Vol. 12, No. 5, November 2005
Copyright C The American Society of Gene Therapy15. Thome, M., et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis
induced by death receptors. Nature 386: 517 – 521.
16. Marshall, J. D., et al. (2003). Identification of a novel CpG DNA class and motif that
optimally stimulate B cell and plasmocytoid dendritic cell functions. J. Leucocyte Biol.
73: 781 – 792.
17. Grimaıˆtre, M., Werner-Favre, C., Kindler, V., and Zubler, R. H. (1997). Human naive B
cells cultured with EL-4 T cells mimic a germinal center-related B cell stage: concordant
changes in Bcl-2 protein and messenger RNA levels. Eur. J. Immunol. 27: 199 – 205.
18. Serafini, M., Naldini, L., and Introna, M. (2004). Molecular evidence of inefficient
transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived
lentivectors. Virology 325: 413 – 424.
19. Bieniasz, P. D. (2004). Intrinsic immunity: a front-line defense against viral attack. Nat.
Immunol. 5: 1109 – 1115.
20. Turelli, P., and Trono, D. (2005). Editing at the crossroads of innate and adaptive
immunity. Science 307: 1061 – 1065.
21. Lens, S. M. A., Tesselaar, K., van Oers, M. H. J., and van Lier, R. A. W. (1998).
Control of lymphocyte function through CD27–CD70 interactions. Semin. Immunol.
10: 491 – 499.
22. Zennou, V., Petit, C., Guetard, D., Nehrbass, U., Mantagnier, L., and Charneau, P.
(2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:
173 – 185.
23. Matthes, T., et al. (1993). Cytokine mRNA expression during an in vitro response of
human B lymphocytes: kinetics of B cell tumor necrosis factor a, interleukin (IL) 6, IL-10
and transforming growth factor h1 mRNAs. J. Exp. Med. 178: 512 – 528.
24. Stripecke, R., et al. (2000). Lentiviral vectors for efficient delivery of CD80 and
granulocyte–macrophage-colony-stimulating factor in human acute lymphoblastic
leukemia and acute myeloid leukemia cells to induce antileukemic immune responses.
Blood 96: 1317 – 1326.
25. Woods, N. B., et al. (2003). Lentiviral vector transduction of NOD/SCID repopulating
cells results in multiple vector integrations per transduced cell: risk of insertional
mutagenesis. Blood 101: 1284 – 1289.
26. Zufferey, R., et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo
gene delivery. J. Virol. 72: 9873 – 9880.
27. Salmon, P., et al. (2000). Reversible immortalization of human primary cells by
lentivector-mediated transfer of specific genes. Mol. Ther. 2: 404 – 414.
28. Leavitt, A. D., Robles, G., Alesandro, N., and Varmus, H. E. (1996). Human
immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet
fail to integrate viral DNA efficiently during infection. J. Virol. 70: 721 – 728.
29. Werner-Favre, C., et al. (2001). IgG subclass-switch capacity is low in switched and in
IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells. Eur. J.
Immunol. 31: 243 – 249.
30. Holler, N., et al. (2003). Two adjacent trimeric Fas ligands are required for Fas signaling
and formation of a death-inducing signaling complex. Mol. Cell. Biol. 23: 1428 – 1440.899
